Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines

David L Crowe, Matt K Lee

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines

Fabrice Journe, Carole Chaboteaux, Nicolas Magne, Hugues Duvillier, Guy Laurent, Jean-Jacques Body

The evolving paradigm of tissue-specific metastasis

Theresa A DiMeo, Charlotte Kuperwasser

Dendritic cell defects in patients with cancer: mechanisms and significance

Corrine Lenahan, David Avigan

Recent translational research: Oncogene discovery by insertional mutagenesis gets a new boost

John Hilkens

Key stages in mammary gland development: The mammary end bud as a motile organ

Lindsay Hinck, Gary B Silberstein

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

Jorge S Reis-Filho, Fernanda Milanezi, Silvia Carvalho, Pete T Simpson, Dawn Steele, Kay Savage, Maryou BK Lambros, Emilio M Pereira, Jahn M Nesland, Sunil R Lakhani, Fernando C Schmitt

The estrogen receptor-α A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study

Kathleen Conway, Eloise Parrish, Sharon N Edmiston, Dawn Tolbert, Chiu-Kit Tse, Joseph Geradts, Chad A Livasy, Harsharan Singh, Beth Newman, Robert C Millikan

Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy

Bruce J Tromberg, Albert Cerussi, Natasha Shah, Montana Compton, Amanda Durkin, David Hsiang, John Butler, Rita Mehta

A common missense variant in BRCA2 predisposes to early onset breast cancer

Bohdan Górski, Steven A Narod, Jan Lubiński

Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective

Anjali S Kumar, Vinona Bhatia, I Craig Henderson

Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer

Stephen W Duffy, Olorunsola Agbaje, Laszlo Tabar, Bedrich Vitak, Nils Bjurstam, Lena Bj？rneld, Jonathan P Myles, Jane Warwick

The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction

Alberto Pinzon-Charry, Chris W Schmidt, José López

Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle

Maria Navarrete, Carolina M Maier, Roberto Falzoni, Luiz Quadros, Geraldo R Lima, Edmund C Baracat, Afonso CP Nazário

Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts

Michael Samoszuk, Jenny Tan, Guillaume Chorn

Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing

Marcus Schmidt, Barbara Lewark, Nikolai Kohlschmidt, Christiane Glawatz, Erik Steiner, Berno Tanner, Henryk Pilch, Wolfgang Weikel, Heinz K？lbl, Hans-Anton Lehr

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

Barry A Gusterson, Douglas T Ross, Victoria J Heath, Torsten Stein

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

Pawel Surowiak, Verena Materna, Rafal Matkowski, Katarzyna Szczuraszek, Jan Kornafel, Andrzej Wojnar, Marek Pudelko, Manfred Dietel, Carsten Denkert, Maciej Zabel, Hermann Lage

Stromal and epithelial TGF-β signaling in mammary tumorigenesis

HL Moses, N Cheng, A Chytil, AE Gorska, M Aakre, E Forrester, EG Neilson, NA Bhowmick

DNA damage response pathways in cancer causation and treatment

MB Kastan, R Kitagawa, CJ Bakkenist

ERβ in normal and malignant breast

J-？ Gustafsson, G Cheng, M Warner

Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat

Véronique Lenoir, Marianne Yon de Jonage-Canonico, Marie-Hélène Perrin, Antoine Martin, Robert Scholler, Bernard Kerdelhué

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells

Gargi D Basu, Latha B Pathangey, Teresa L Tinder, Sandra J Gendler, Pinku Mukherjee

Designing a HER2/neu promoter to drive α1,3galactosyltransferase expression for targeted anti-αGal antibody-mediated tumor cell killing

Marion Lanteri, Laurence Ollier, Valérie Giordanengo, Jean-Claude Lefebvre

Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2

Jonas Cicenas, Patrick Urban, Vincent Vuaroqueaux, Martin Labuhn, Willy Küng, Edward Wight, Mark Mayhew, Urs Eppenberger, Serenella Eppenberger-Castori

The roles of PET and CT/PET as preoperative studies

RC Delgado-Bolton, JL Carreras Delgado

Present situation and future of genetic profiling for prognosis and treatment

GN Hortobagyi

Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients

RC Coombes, MT De Bella, G Tripuraneni, A Zaidi, S Anwer, DA Stephens, B Ward, HD Sinnett, MJ Slade

Menopausal hormone therapy after breast cancer

Graham A Colditz

Estrogen-repressed genes – key mediators of estrogen action?

Simeen Zubairy, Steffi Oesterreich

Biological features and xenograft models of a very early human premalignant breast lesion

S Lee, Y Wu, SK Mohsin, D Medina, DC Allred

A breast cancer progression model: the importance of three-dimensional tissue architecture and metalloproteinases

MJ Bissell, C Myers, G Lee, E Lee, A Rizki, S Mian, J Gray, D Radisky

Predicting response/resistance to endocrine therapy for breast cancer

WR Miller, TJ Anderson, D Evans, A Krause, JM Dixon

Mammary epithelial cell transformation: insights from cell culture and mouse models

Goberdhan Dimri, Hamid Band, Vimla Band

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer

JGM Klijn, EMJJ Berns, J Martens, MPHM Jansen, D Atkins, JA Foekens, Y Wang

The role of gene expression profiling by microarray analysis for prognostic classification of breast cancer

MJ van de Vijver

Expression profiling of peripheral blood cells for early detection

A-L B？rresen-Dale, P Sharma

Imaging in breast cancer: Magnetic resonance spectroscopy

Patrick J Bolan, Michael T Nelson, Douglas Yee, Michael Garwood

Do breast implants after a mastectomy affect subsequent prognosis and survival?

Louise A Brinton

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast

Arno Kuijper, Petra van der Groep, Elsken van der Wall, Paul J van Diest

Neoadjuvant treatment: the MD Anderson experience

GN Hortobagyi

Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract

M Waheed Roomi, Nusrath W Roomi, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki, Matthias Rath

Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit

PM Ravdin

Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt

Ahmed Ahmed, James D Brenton

TP53-binding protein variants and breast cancer risk: a case-control study

Bernd Frank, Kari Hemminki, Justo Bermejo, Rüdiger Klaes, Peter Bugert, Barbara Wappenschmidt, Rita K Schmutzler, Barbara Burwinkel

Partial breast irradiation: why and how

FA Calvo, JA Díaz, á Montero, A álvarez González

Endocrinology and hormone therapy in breast cancer: Selective oestrogen receptor modulators and downregulators for breast cancer – have they lost their way?

Stephen RD Johnston

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women

Kathleen Pritchard

Primary chemotherapy for operable breast cancer: the NSABP experience

HD Bear

Radiotherapy in early stage invasive breast cancer: current tendencies

JA Diaz-Gonzalez, KH Shin, R Martinez-Monge, M Zelefsky

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705